These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19021283)

  • 1. Paradoxical embolism through the patent foramen ovale--the elderly is where the money is.
    Meier B
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):971-2. PubMed ID: 19021283
    [No Abstract]   [Full Text] [Related]  

  • 2. Another addition to the tool box.
    Tuzcu EM
    Catheter Cardiovasc Interv; 2008 May; 71(6):829-30. PubMed ID: 18412080
    [No Abstract]   [Full Text] [Related]  

  • 3. Closure of patent foramen ovale: The abolition of stroke and asymptotic realities.
    Tan WA
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):517-8. PubMed ID: 15274164
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
    Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.
    Spies C; Khandelwal A; Timmemanns I; Kavinsky CJ; Schräder R; Hijazi ZM
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):966-70. PubMed ID: 18942060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry.
    Alameddine F; Block PC
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):512-6. PubMed ID: 15274163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
    Carroll JD
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1070-1. PubMed ID: 19950331
    [No Abstract]   [Full Text] [Related]  

  • 8. Late complications of transcatheter closure of patent foramen ovale: new technology and new outcomes.
    Staubach S; Bertog S; Wunderlich N; Sievert H
    Future Cardiol; 2009 Sep; 5(5):503-10. PubMed ID: 19715414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
    Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of recurrent stroke after percutaneous closure of patent foramen ovale.
    Rudolph V; Augustin J; Hofmann T; Hamm CW; Meinertz T; Köster R; Baldus S; Franzen O
    EuroIntervention; 2014; 9(12):1418-22. PubMed ID: 24169021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PFO and paradoxical embolism producing events other than stroke.
    Dao CN; Tobis JM
    Catheter Cardiovasc Interv; 2011 May; 77(6):903-9. PubMed ID: 21207422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
    Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent foramen ovale and cryptogenic stroke: a complex neuro-cardio-vascular problem.
    Spies C; Wong M
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1455-67. PubMed ID: 19900028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ultimate proof of paradoxical embolism and a percutaneous solution.
    Osten MD; Horlick EM
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):837-40. PubMed ID: 18798242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic significant patent foramen ovale: giving patent foramen ovale management back to the cardiologist.
    Rigatelli G; Cardaioli P; Chinaglia M
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):573-7. PubMed ID: 18307240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
    Harms V; Reisman M; Fuller CJ; Spencer MP; Olsen JV; Krabill KA; Gray WA; Jesurum JT
    Am J Cardiol; 2007 May; 99(9):1312-5. PubMed ID: 17478164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shut that door: a man with contemporaneous multisite paradoxical embolization.
    Rigatelli G; Dell'Avvocata F; Cardaioli P; Giordan M; Bernasconi M; Palu' M
    Cardiovasc Revasc Med; 2009; 10(2):125-7. PubMed ID: 19327676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migraine and patent foramen ovale: headache for patient and cardiologist.
    Blankenship JC
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):505-6. PubMed ID: 20333664
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent foramen ovale and cryptogenic stroke.
    Jaquis J
    Dimens Crit Care Nurs; 2007; 26(6):233-6. PubMed ID: 18090138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent foramen ovale closure for migraine prevention: the subject is still open.
    Dodick DW
    JACC Cardiovasc Interv; 2010 Mar; 3(3):288-9. PubMed ID: 20298986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.